Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy
- PMID: 34549045
- PMCID: PMC8450453
- DOI: 10.1183/23120541.00407-2021
Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy
Abstract
Ruxolitinib could be considered as an option in the treatment of LONIPCs in children when other treatments are ineffective. Spirometry is a valuable tool for both diagnosis and follow-up of LONIPCs in children. https://bit.ly/3BmOYfb.
Copyright ©The authors 2021.
Conflict of interest statement
Conflict of interest: The authors have no conflicts of interest relevant to this article to disclose.
Figures
References
-
- Carreras E, Cooke KR. Noninfectious pulmonary complications. In:Carreras E, Dufour C, Mohty M, et al., eds. The EBMT Handbook: Hematopoietic Stem Cell Transplantation and Cellular Therapies. 7th Edn. Cham, Springer, 2019; pp. 393–407. - PubMed
LinkOut - more resources
Full Text Sources